OAB-048: Suboptimal humoral immune response to SARS-CoV-2 mRNA vaccination in myeloma patients is associated with anti-CD38 mAb and BCMA-targeted treatment
Titel:
OAB-048: Suboptimal humoral immune response to SARS-CoV-2 mRNA vaccination in myeloma patients is associated with anti-CD38 mAb and BCMA-targeted treatment
Auteur:
Oekelen, Oliver Van Agte, Sarita Gleason, Charles Srivastava, Komal Beach, Katherine Aleman, Adolfo Upadhyaya, Bhaskar Kappes, Katerina Mouhieddine, Tarek Wang, Bo Chari, Ajai Cordon-Cardo, Carlos Krammer, Florian Jagannath, Sundar Simon, Viviana Wajnberg, Ania Parekh, Samir